CEO exercised or converted 55K DGX derivative securities | OQRO Insider trades- Derivative units · @ $95.80
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 25, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 28, 2025
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001022079-25-000233
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerQUEST DIAGNOSTICS INC Reporting personJ. E. Davis RelationshipDirector, Officer Officer titleCEO and President SecurityNon-Qualifed Stock Option (right to buy) TableDerivative (Table II) Transaction dateNov 25, 2025 Acquired / disposedDisposed (D) Footnotes from the filing
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Around the same time
Julie Johnson soldDemocrat, Representative, TX district 32D · TX-32Held by the filer's joint per the disclosure. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
A board member of Quest Diagnostics sold $240K of Quest Diagnostics shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.